title: Effect of dietary hempseed intake on cardiac ischemia-reperfusion injury.
abstract: Polyunsaturated fatty acids (PUFAs) have significant, cardioprotective effects against ischemia. Hempseed contains a high proportion of the PUFAs linoleic acid (LA) and alpha-linolenic acid (ALA), which may have opposing effects on postischemic heart performance. There are no reported data concerning the cardiovascular effects of dietary hempseed intake. A group of 40 male Sprague-Dawley rats were distributed evenly into four groups that were fed for 12 wk a normal rat chow supplemented with hempseed (5% and 10%), palm oil (1%), or a 10% partially delipidated hempseed that served as a control. Plasma ALA and gamma-linolenic acid levels were significantly elevated in the rats that were fed a 5% or 10% hempseed-supplemented diet, but in heart tissue only ALA levels were significantly elevated in the rats fed these diets compared with control. After the dietary interventions were completed, postischemic heart performance was evaluated by measuring developed tension, resting tension, the rates of tension development and relaxation, and the number of extrasystoles. Hearts from rats fed a hempseed-supplemented diet exhibited significantly better postischemic recovery of maximal contractile function and enhanced rates of tension development and relaxation during reperfusion than hearts from the other groups. These hearts, however, were not protected from the occurrence of extrasystoles, nor were the increases in resting tension altered during ischemia or reperfusion as a function of any dietary intervention. Our data demonstrate that dietary hempseed can provide significant cardioprotective effects during postischemic reperfusion. This appears to be due to its highly enriched PUFA content.
authors.affiliation: Canadian Centre for Agri-food Research in Health and Medicine, St. Boniface Hospital Research Centre, 351 Tache Avenue, Winnipeg, Manitoba, Canada R2H 2A6.
authors.forename: A
authors.initials: A
authors.lastname: Al-Khalifa
authors.forename: T G
authors.initials: TG
authors.lastname: Maddaford
authors.forename: M N
authors.initials: MN
authors.lastname: Chahine
authors.forename: J A
authors.initials: JA
authors.lastname: Austria
authors.forename: A L
authors.initials: AL
authors.lastname: Edel
authors.forename: M N
authors.initials: MN
authors.lastname: Richard
authors.forename: B P
authors.initials: BP
authors.lastname: Ander
authors.forename: N
authors.initials: N
authors.lastname: Gavel
authors.forename: M
authors.initials: M
authors.lastname: Kopilas
authors.forename: R
authors.initials: R
authors.lastname: Ganguly
authors.forename: P K
authors.initials: PK
authors.lastname: Ganguly
authors.forename: G N
authors.initials: GN
authors.lastname: Pierce
mesh_terms: D000818:Animals; D004042:Dietary Fats, Unsaturated / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D019587:Dietary Supplements; D006321:Heart / Q000187:drug effects*; D019787:Linoleic Acid / Q000097:blood / Q000494:pharmacology; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control; D009206:Myocardium / Q000378:metabolism; D010938:Plant Oils / Q000008:administration & dosage / Q000494:pharmacology*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D017962:alpha-Linolenic Acid / Q000097:blood / Q000494:pharmacology
chemical_list: D004042:Dietary Fats, Unsaturated; D010938:Plant Oils; D017962:alpha-Linolenic Acid; D019787:Linoleic Acid